Pfizer's latest COVID-19 shot targets fading variant amid permanent Health Canada shortcuts
Canada’s health regulator authorized the new vaccine through a permanent licensing pathway that bypasses rigorous trials, and critics warn prioritizes corporate interests over safety, transparency, and long-term data for these products.